STOCK TITAN

Hologic (HOLX) insider Form 4 shows 337 shares withheld for taxes

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Hologic Inc. (HOLX) disclosed an insider equity transaction by its General Counsel on a Form 4. On 11/14/2025, 337 shares of Hologic common stock were disposed of at $74.15 per share under transaction code "F", meaning the shares were withheld to cover tax obligations related to the settlement of previously granted restricted stock units whose service-based vesting conditions had been met. After this tax withholding, the officer directly beneficially owns 28,237 shares of Hologic common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Liddy Anne M.

(Last) (First) (Middle)
250 CAMPUS DRIVE

(Street)
MARLBOROUGH MA 01752

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
HOLOGIC INC [ HOLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
11/14/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/14/2025 F 337(1) D $74.15 28,237 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied.
/s/ Mark W. Irving, attorney-in-fact for Ms. Liddy 11/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Hologic (HOLX) report on this Form 4?

The filing reports that Hologic's General Counsel disposed of 337 shares of common stock on 11/14/2025 under transaction code "F", reflecting shares withheld to satisfy tax obligations tied to restricted stock units that had vested.

How many Hologic (HOLX) shares were involved and at what price?

The Form 4 shows 337 shares of Hologic common stock were disposed of at a price of $74.15 per share in connection with tax withholding on vested restricted stock units.

How many Hologic (HOLX) shares does the insider own after this transaction?

Following the reported tax-withholding transaction, the General Counsel directly beneficially owns 28,237 shares of Hologic common stock.

Was this Hologic (HOLX) insider transaction an open-market sale?

No. The transaction is coded "F" and the explanation states that the 337 shares were withheld to cover tax obligations upon settlement of restricted stock units, rather than being sold in an open-market trade.

What is the role of the reporting person in Hologic (HOLX)?

The reporting person is an officer of Hologic, serving as General Counsel, and is therefore required to report transactions in Hologic equity securities on Form 4.

What does the explanation say about the Hologic (HOLX) RSU transaction?

The explanation states that the 337 shares were "withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied."

Hologic Inc

NASDAQ:HOLX

HOLX Rankings

HOLX Latest News

HOLX Latest SEC Filings

HOLX Stock Data

16.68B
221.38M
0.86%
101.02%
1.4%
Medical Instruments & Supplies
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
MARLBOROUGH